EP 4034171 A1 20220803 - ANTI-CD47 ANTIBODIES, ACTIVATABLE ANTI-CD47 ANTIBODIES, AND METHODS OF USE THEREOF
Title (en)
ANTI-CD47 ANTIBODIES, ACTIVATABLE ANTI-CD47 ANTIBODIES, AND METHODS OF USE THEREOF
Title (de)
ANTI-CD47-ANTIKÖRPER, AKTIVIERBARE ANTI-CD47-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG DAVON
Title (fr)
ANTICORPS ANTI-CD47, ANTICORPS ANTI-CD47 ACTIVABLES, ET LEURS MÉTHODES D'UTILISATION
Publication
Application
Priority
- US 201962904534 P 20190923
- US 2020052332 W 20200923
Abstract (en)
[origin: WO2021061867A1] The invention relates generally to activatable antibodies that bind to CD47 and methods of making and using these activatable antibodies in a variety of therapeutic, prophylactic, and diagnostic contexts. In some embodiments, the CD47 activatable antibodies bind human and cynomolgus monkey CD47.
IPC 8 full level
A61K 47/68 (2017.01); C07K 16/28 (2006.01)
CPC (source: EP)
A61K 47/6849 (2017.07); A61K 47/6891 (2017.07); C07K 16/2803 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/72 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C07K 2319/50 (2013.01)
Citation (search report)
See references of WO 2021061867A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2021061867 A1 20210401; CN 114650844 A 20220621; EP 4034171 A1 20220803; JP 2022548310 A 20221117
DOCDB simple family (application)
US 2020052332 W 20200923; CN 202080076276 A 20200923; EP 20789345 A 20200923; JP 2022518171 A 20200923